MMJ Recs

MARCH 2, 2024

In Ohio, accessing medical marijuana involves more than just obtaining a prescription; it requires navigating a complex landscape of dispensaries, regulations, and patient expectations. This guide aims to demystify the process, offering practical advice and insights to help patients make informed decisions.

Dispensary 52

Dispensary Patients Marijuana Education 52

MMJ Recs

MARCH 16, 2024

Regulatory Framework and Policy Implications The regulatory framework governing the medical marijuana industry has profound implications for businesses, consumers, and society as a whole. Regulations vary significantly by jurisdiction but typically encompass licensing requirements, product safety standards, and distribution protocols.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Cannabis Law Report

MARCH 20, 2019

CCIA Policy Conference What’s Missing? – On Wednesday, March 20, 2019, the California Cannabis Industry Association (“CCIA”) will host its 4th Annual Policy Conference in Sacramento, California. 2019 Policy Development & Legislation , moderated by Amy Jenkins, CCIA.

Policy 51

Policy Collective Business Legislation 51

Cannabis Law Report

SEPTEMBER 11, 2021

The position provides daily oversight of complaints of product safety issues, non-compliance, and patient safety issues, qualified personnel registration, as well as application and renewal process for all licenses issued by the Commission. Participate in training seminars and workshops.

Compliance 105

Compliance Compliance Seed-To-Sale Data 105

Cannabis Law Report

JUNE 15, 2021

The position provides daily oversight of complaints of product safety issues, non-compliance, and patient safety issues, qualified personnel registration, as well as application and renewal process for all licenses issued by the Commission. Participate in training seminars and workshops.

Compliance 105

Compliance Compliance Seed-To-Sale Data 105

Cannabis Law Report

MAY 18, 2022

A recent publication in the prominent peer-reviewed journal Nature, shows that 67% of patients no longer qualified for a PTSD diagnosis a year after treatment with MDMA (or “ecstasy”). READ DOC OF WHAT’S HAPPENING. The clinical evidence for psychedelic assisted therapy is accumulating.

Research and Development 52

Research and Development Therapy Treatment Policy 52

Cannabis Law Report

SEPTEMBER 18, 2021

The position provides daily oversight of complaints of product safety issues, non-compliance, and patient safety issues, qualified personnel registration, as well as application and renewal process for all licenses issued by the Commission. Participate in training seminars and workshops.

Compliance 52

Compliance Compliance Seed-To-Sale Data 52